Sotheby’s Poison Pill Challenged by Third Point at Trial Sotheby’s (BID) is misusing an anti-takeover defense to hinder Third Point LLC’s proxy fight to add directors to the auction house’s board, a lawyer for the hedge fund argued.
April 29, 2014 - Bloomberg